ArticleFrontiers in oncology2022

Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.

Mitsuaki Tatsumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.